Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
Envoy Medical Inc. (COCHW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
02/25/2026: COCHW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 2.27 | 52 Weeks Range 0.03 - 0.10 | Updated Date 06/28/2025 |
52 Weeks Range 0.03 - 0.10 | Updated Date 06/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -11102.17% |
Management Effectiveness
Return on Assets (TTM) -129.07% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 10658404 |
Shares Outstanding - | Shares Floating 10658404 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Envoy Medical Inc.
Company Overview
History and Background
Envoy Medical Inc. is a medical device company focused on developing and commercializing innovative solutions for hearing loss. The company's journey began with a vision to transform the treatment of hearing loss through advanced technology and a patient-centric approach. Significant milestones have included the development of their proprietary implantable hearing devices, clinical trials, and regulatory submissions. Envoy Medical has evolved by focusing on a unique, implantable hearing device that aims to provide a more natural hearing experience compared to traditional hearing aids or cochlear implants.
Core Business Areas
- Implantable Hearing Devices: Envoy Medical's core business revolves around the research, development, and commercialization of fully implantable hearing devices. These devices are designed to address moderate to severe hearing loss by directly stimulating the middle or inner ear structures, offering a potential alternative to external hearing aids or cochlear implants.
Leadership and Structure
Envoy Medical Inc. is led by a management team with expertise in medical devices, audiology, and business development. The organizational structure is typical of a medical device company, with dedicated departments for research and development, clinical affairs, regulatory affairs, sales, and marketing. Specific details on the current leadership team and detailed organizational charts are best obtained from their official investor relations or company website.
Top Products and Market Share
Key Offerings
- Envoy Medical Esteemu00ae: The Esteemu00ae is Envoy Medical's flagship product, a fully implantable hearing device designed for individuals with moderate to severe sensorineural hearing loss. Unlike traditional hearing aids that amplify sound externally, Esteem is implanted surgically and uses the body's natural structures to transmit sound. Market share data for this specific niche product is difficult to ascertain publicly, as it competes within the broader hearing loss treatment market, which includes hearing aids and cochlear implants. Key competitors in the broader hearing loss market include Sonova (Phonak, Unitron), Demant (Oticon, Bernafon), WS Audiology (Widex, Signia), GN Hearing (ReSound, Beltone), and Cochlear Limited.
Market Dynamics
Industry Overview
Envoy Medical operates within the global hearing loss treatment market, a sector driven by an aging population, increasing awareness of hearing health, and technological advancements. The market encompasses a range of solutions, from traditional hearing aids to advanced implantable devices. There's a growing demand for discreet, effective, and personalized hearing solutions.
Positioning
Envoy Medical positions itself as a pioneer in fully implantable hearing devices, offering a unique solution that aims to be invisible and provide a more natural hearing experience. Their competitive advantage lies in their proprietary technology that fully integrates with the body, potentially offering benefits over external devices.
Total Addressable Market (TAM)
The total addressable market for hearing loss solutions is substantial, with estimates varying but generally in the tens of billions of dollars globally. Envoy Medical's TAM is specifically focused on the segment of the market for individuals with moderate to severe hearing loss who are candidates for implantable devices. While they are a niche player, their innovative approach targets a significant unmet need within this broader market.
Upturn SWOT Analysis
Strengths
- Proprietary fully implantable hearing device technology.
- Potential for a more natural hearing experience compared to traditional hearing aids.
- Invisibility and convenience of an implanted device.
- Focus on a specific segment of the hearing loss market.
Weaknesses
- Relatively new to the market with limited brand recognition compared to established players.
- Requires surgical implantation, which may deter some patients.
- Dependence on a single core product for revenue.
- Capital intensive research and development, and regulatory processes.
Opportunities
- Growing global prevalence of hearing loss.
- Increasing acceptance and demand for advanced medical technologies.
- Expansion into new geographic markets.
- Potential for further technological advancements and product line extensions.
Threats
- Intense competition from established hearing aid and cochlear implant manufacturers.
- Reimbursement challenges from healthcare payers.
- Potential for new disruptive technologies in the hearing loss market.
- Economic downturns affecting discretionary spending on medical devices.
Competitors and Market Share
Key Competitors
- Sonova Holding AG (SWX:SOON)
- Demant A/S (CPH:DEMANT)
- WS Audiology
- GN Store Nord A/S (CPH:GN)
- Cochlear Limited (ASX:COH)
Competitive Landscape
Envoy Medical faces a highly competitive landscape dominated by large, established hearing aid manufacturers with extensive distribution networks and brand loyalty. Their advantage lies in their unique fully implantable technology, which differentiates them from traditional hearing aids and even cochlear implants. However, they need to overcome the challenges of surgical requirements and educate the market about their novel solution.
Growth Trajectory and Initiatives
Historical Growth: Historical growth for Envoy Medical has likely been characterized by significant investment in R&D, successful clinical trials, and regulatory approvals. Revenue growth would be nascent as they scale commercialization efforts.
Future Projections: Future projections for Envoy Medical are contingent on successful market adoption of their Esteemu00ae device, expansion of their sales and distribution network, and potential regulatory approvals for new indications or improved product versions. Analyst estimates, if available, would provide insights into projected revenue and profitability.
Recent Initiatives: Recent initiatives likely include scaling up manufacturing, building out their sales force, increasing marketing efforts to raise awareness among audiologists and potential patients, and potentially pursuing further funding rounds to support growth.
Summary
Envoy Medical Inc. is an innovative medical device company with a unique fully implantable hearing device. Its strength lies in its proprietary technology addressing a significant unmet need in the hearing loss market. However, it faces considerable challenges from established competitors, the requirement for surgical intervention, and the need for substantial market education and reimbursement. Continued success hinges on demonstrating clinical efficacy, achieving widespread adoption by healthcare professionals and patients, and navigating the complex regulatory and reimbursement landscape.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Envoy Medical Inc. investor relations materials (if publicly available)
- SEC filings (e.g., 10-K, 10-Q)
- Industry reports on the hearing loss market
- Financial news and analysis platforms
Disclaimers:
This JSON output is based on publicly available information and general industry knowledge. It is not financial advice. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Market share data and financial metrics are estimates and subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envoy Medical Inc.
Exchange NASDAQ | Headquaters White Bear Lake, MN, United States | ||
IPO Launch date 2021-04-23 | CEO & Director Mr. Brent T. Lucas Esq. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 42 | Website https://www.envoymedical.com |
Full time employees 42 | Website https://www.envoymedical.com | ||
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.